Medtronic Board appoints Dr. Joon Lee as a new director
Medtronic (NYSE:MDT) has appointed Dr. Joon Lee, CEO of Emory Healthcare, to its Board of Directors as an independent director, effective June 18, 2025. Dr. Lee, who will serve on the Science and Technology Committee and Compensation and Talent Committee, brings over 25 years of healthcare leadership experience.
Currently leading Emory Healthcare's $7.7B healthcare system with 12 hospitals and 29,000+ employees, Dr. Lee previously held executive positions at UPMC, including Executive VP and President of Physician Services. He also served as CMO of UPMC Insurance Services, managing a $13B health insurance division. His expertise spans interventional cardiology, clinical research, and healthcare technology.
Medtronic (NYSE:MDT) ha nominato il Dott. Joon Lee, CEO di Emory Healthcare, nel suo Consiglio di Amministrazione come direttore indipendente, con effetto dal 18 giugno 2025. Il Dott. Lee, che farà parte del Comitato Scienza e Tecnologia e del Comitato Retribuzioni e Talenti, porta con sé oltre 25 anni di esperienza nella leadership sanitaria.
Attualmente guida il sistema sanitario di Emory Healthcare, del valore di 7,7 miliardi di dollari, che comprende 12 ospedali e più di 29.000 dipendenti. In precedenza, il Dott. Lee ha ricoperto ruoli esecutivi presso UPMC, tra cui Vicepresidente Esecutivo e Presidente dei Servizi Medici. Ha inoltre svolto il ruolo di CMO di UPMC Insurance Services, gestendo una divisione assicurativa sanitaria da 13 miliardi di dollari. La sua esperienza copre cardiologia interventistica, ricerca clinica e tecnologia sanitaria.
Medtronic (NYSE:MDT) ha nombrado al Dr. Joon Lee, CEO de Emory Healthcare, como miembro independiente de su Junta Directiva, efectivo a partir del 18 de junio de 2025. El Dr. Lee, quien formará parte del Comité de Ciencia y Tecnología y del Comité de Compensación y Talento, aporta más de 25 años de experiencia en liderazgo sanitario.
Actualmente dirige el sistema de salud de Emory Healthcare, valorado en 7.7 mil millones de dólares, que cuenta con 12 hospitales y más de 29,000 empleados. Anteriormente, el Dr. Lee ocupó cargos ejecutivos en UPMC, incluyendo Vicepresidente Ejecutivo y Presidente de Servicios Médicos. También fue CMO de UPMC Insurance Services, gestionando una división de seguros de salud de 13 mil millones de dólares. Su experiencia abarca cardiología intervencionista, investigación clínica y tecnología sanitaria.
메드트로닉 (NYSE:MDT)은 2025년 6월 18일부로 Emory Healthcare의 CEO인 Dr. Joon Lee를 독립 이사로 이사회에 임명했습니다. Dr. Lee는 과학 및 기술 위원회와 보상 및 인재 위원회에서 활동할 예정이며, 25년 이상의 의료 리더십 경험을 보유하고 있습니다.
현재 Dr. Lee는 12개 병원과 29,000명 이상의 직원을 보유한 77억 달러 규모의 Emory Healthcare 의료 시스템을 이끌고 있습니다. 이전에는 UPMC에서 최고운영책임자(Executive VP) 및 의사 서비스 부문 사장(President of Physician Services) 등 임원직을 역임했으며, 130억 달러 규모의 건강 보험 부문을 관리하는 UPMC Insurance Services의 최고의료책임자(CMO)로도 근무했습니다. 그의 전문 분야는 중재적 심장학, 임상 연구 및 의료 기술입니다.
Medtronic (NYSE:MDT) a nommé le Dr Joon Lee, PDG d'Emory Healthcare, au sein de son Conseil d'administration en tant qu'administrateur indépendant, à compter du 18 juin 2025. Le Dr Lee, qui siégera au Comité Science et Technologie ainsi qu'au Comité Rémunération et Talents, apporte plus de 25 ans d'expérience en leadership dans le secteur de la santé.
Actuellement à la tête du système de santé d'Emory Healthcare, d'une valeur de 7,7 milliards de dollars, comprenant 12 hôpitaux et plus de 29 000 employés, le Dr Lee a précédemment occupé des postes de direction chez UPMC, notamment Vice-Président Exécutif et Président des Services Médicaux. Il a également été CMO de UPMC Insurance Services, gérant une division d'assurance santé de 13 milliards de dollars. Son expertise couvre la cardiologie interventionnelle, la recherche clinique et la technologie médicale.
Medtronic (NYSE:MDT) hat Dr. Joon Lee, CEO von Emory Healthcare, mit Wirkung zum 18. Juni 2025 als unabhängiges Mitglied in den Vorstand berufen. Dr. Lee wird im Wissenschafts- und Technikausschuss sowie im Vergütungs- und Talentkomitee tätig sein und bringt über 25 Jahre Führungserfahrung im Gesundheitswesen mit.
Derzeit leitet Dr. Lee das 7,7 Milliarden US-Dollar umfassende Gesundheitssystem von Emory Healthcare mit 12 Krankenhäusern und über 29.000 Mitarbeitern. Zuvor hatte er Führungspositionen bei UPMC inne, darunter Executive VP und Präsident der ärztlichen Dienste. Außerdem war er CMO von UPMC Insurance Services und leitete eine 13 Milliarden US-Dollar schwere Krankenversicherungsabteilung. Seine Expertise umfasst interventionelle Kardiologie, klinische Forschung und Gesundheitstechnologie.
- Appointment of highly qualified healthcare executive with 25+ years of leadership experience
- Addition of expertise in both clinical practice and healthcare system management
- Strategic enhancement of board competencies in technology and healthcare operations
- Brings experience managing large-scale healthcare operations ($7.7B Emory Healthcare system)
- None.
"We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtronic's Board of Directors," said Geoff Martha, chairman and chief executive officer. "Dr. Lee brings deep expertise as a clinical researcher, academic leader, and physician executive with decades of broad leadership across healthcare. He is passionate about leveraging data and technology to improve the patient and provider experience—insights that will help us further our Mission to alleviate pain, restore health, and extend life for patients around the world."
In his current role as CEO of Emory Healthcare, Inc., Dr. Lee oversees the most comprehensive academic health system in
Dr. Lee's distinguished career spans more than 25 years at the University of Pittsburgh Medical Center (UPMC), where he held pivotal roles, including Executive Vice President and President of Physician Services. There, his scope included physician services, patient experience, patient access and financial oversight of physician services. He also served as Vice Dean of Clinical Affairs at the University of Pittsburgh School of Medicine.
Additionally, Dr. Lee served as Chief of the Division of Cardiology and was the founding executive director of the UPMC Heart and Vascular Institute. From 2019 to 2021, Dr. Lee was the Chief Medical Officer of UPMC Insurance Services, a
Dr. Lee is certified in cardiovascular disease by the American Board of Internal Medicine. He is a fellow in the American College of Cardiology and Society for Coronary Angiography and Interventions. He completed a medical internship and residency, as well as two cardiology fellowships in cardiology and interventional cardiology, at Massachusetts General Hospital in
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in
Contacts: | |
Erika Winkels | Ryan Weispfenning |
Public Relations | Investor Relations |
+1-612-558-8932 | +1-763-505-4626 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-board-appoints-dr-joon-lee-as-a-new-director-302488605.html
SOURCE Medtronic plc
FAQ
Who is Dr. Joon Lee and what is his new role at Medtronic (NYSE:MDT)?
What experience does Dr. Joon Lee bring to Medtronic's board?
Which committees will Dr. Lee serve on Medtronic's board?
What is Dr. Lee's current role outside of Medtronic?
